#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chondrosarcoma metastatic IgA nephropathy Anal cancer recurrent Oesophageal adenocarcinoma stage II Kidney transplant rejection Leukocyte adhesion deficiency type I Gastroenteropancreatic neuroendocrine tumour disease Follicular lymphoma stage I Myotonic dystrophy Brain abscess Breast angiosarcoma Rhabdoid tumour Neurofibromatosis Ureteric cancer Obliterative bronchiolitis More trials…

    Learn about Rare Diseases

    Pelizaeus-Merzbacher disease – Treatment Breast angiosarcoma KBG syndrome – Trials in Disease Systemic sclerosis pulmonary – Trials in Disease Hypereosinophilic syndrome – Basic Information Waldenstrom’s macroglobulinaemia – Life with Disease Pemphigoid – Treatment Crigler-Najjar syndrome – Life with Disease Richter’s syndrome – Diagnostics IgA nephropathy – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sabatolimab Isoniazid Gskvx000000009151 Gs-1427 Eik1003 Cytisinicline Fosinopril Sodium Milnacipran Hydrochloride Estradiol Hemihydrate Amifostine Thiol Norfloxacin Mexiletine Nilutamide SP16 Bifikafusp Alfa Yttrium-90 Vb10.16 METHYLPHENIDATE Sodium Alginate Lidocaine Hydrochloride More therapies…

    Learn about Your Condition

    Gouty arthritis Open angle glaucoma Optic glioma Transitional cell carcinoma Hypotension B-cell type acute leukaemia Dry mouth Endometrial stromal sarcoma Prolymphocytic leukaemia Klinefelter's syndrome Liposarcoma metastatic Alveolar proteinosis Overweight Lung adenocarcinoma stage III Nephroblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Epilepsy

  • Study on the Safety and Effectiveness of Sirolimus and Vigabatrin for Preventing Symptoms in Infants with Tuberous Sclerosis Complex

    Recruiting

    4 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    • Epilepsy
    Investigated Drugs:
    • Vigabatrin
    • Sirolimus
    Poland

  • Study on the Effectiveness and Safety of Sirolimus for Patients with Drug-Resistant Epilepsy Linked to Tuberous Sclerosis Complex

    Recruiting

    3 1 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    • Epilepsy
    Investigated Drugs:
    • Sirolimus
    Poland

  • Study on the Effectiveness and Safety of Levetiracetam XR for Patients with Drug-Resistant Partial Onset Epilepsy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • Levetiracetam
    Bulgaria Czechia Germany Greece Hungary Italy +3

  • Study on Cannabidiol and Dronabinol for Children with Refractory Epilepsy

    Recruiting

    3 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • Cannabidiol
    • Dronabinol
    The Netherlands

  • Study on Clioquinol for Reducing Seizures in Patients with Drug-Resistant Epilepsy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Epilepsy
    Investigated Drugs:
    • Clioquinol
    Belgium

  • Phase 2 Study Evaluating OV329 on Photo‑Induced EEG Response in Adults with Epilepsy

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Epilepsy
    The Netherlands
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!